Coexistence of B-Cell Dyscrasia with Large Granular Lymphocytic Leukemia

医学 基因重排 白血病 精神障碍 免疫学 淋巴细胞增多症 人口 骨髓 病理 生物 遗传学 环境卫生 基因 等离子体电池
作者
Hassan Awada,Jibran Durrani,Ashwin Kishtagari,Valeria Visconte,Reda Z. Mahfouz
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 3750-3750
标识
DOI:10.1182/blood-2019-132220
摘要

Large granular lymphocytic leukemia (LGLL) is an indolent disease and often associated with autoimmune disorders such as rheumatoid arthritis. The association of humoral immune disorders resulting from abnormal B cell activity, may affect original LGLL pathogenesis, clinical presentation and management through modifying disease presentation, progression and/ or resistance to standard care. Coexistence of T cell LGL leukemia with B cell abnormalities has previously been identified in the literature although described in sporadic case reports. However, no large case series or cohorts have been collected so far to study the frequency of the B-cell dyscrasia (BCD) associated with LGLL and describe clinical/ hematological findings in patients with this co-association. Here, we conducted a retrospective review of patients diagnosed with LGL leukemia at The Cleveland Clinic Foundation to search for any associated BCDs. We then classified our population into 2 groups: LGLL with BCD vs. LGLL without BCD, and comprehensively compared them for baseline, clinical and molecular characteristics. A total of 244 T-LGL patients were collected and studied. All cases were uniformly diagnosed with LGLL if 3 out of 4 following criteria were fulfilled, including: 1) LGL count >500/µL in blood for more than 6 months; 2) presence of abnormal CTLs expressing CD3, CD8 and CD57 by flow cytometry; 3) preferential usage of a TCR Vβ family by flow cytometry; 4) TCR gene rearrangement by PCR. Molecular studies including targeted deep sequencing for STAT3mutations were performed. Bone marrow biopsy results were reviewed to exclude other conditions. Endpoints of the study were death or lost to follow up. In our cohort, we found a frequent manifestation of humoral immune system abnormalities. We identified coexisting BCD in 45% (109/ 244) of LGLL patients, of whom 28 (11.2%) had monoclonal gammopathy of unknown significance (MGUS), and 13 (5.2%) had chronic lymphocytic leukemia (CLL/SLL). Six LGLL patients had multiple myeloma (2.4%). Moreover, polyclonal hypergammaglobulinemia (n=28, 11.2%) or hypogammaglobulinemia (n=14, 5.6%) was reported in 42 LGLL-patients (16.8%). The frequency of other disorders of B-cell origin was also examined. The total incidence of B-cell abnormalities in our LGLL cohort was 45%. Indeed an heterogeneous appearance of other B-cell disorders was observed including mantle cell lymphoma (n=2), DLBCL (n=6), marginal zone lymphoma (n=3), Waldenstrom's macroglobulinemia (n=1), Burkitt's lymphoma (n=1), indolent lymphoma (n=1), Hodgkin's lymphoma (n=1), non-Hodgkin's lymphoma (n=3), neck lymphoma (n=1), and smoldering myeloma (n=2). Patient with LGLL-BCD were older as compared to the ones without (median age: 62 vs. 63 years; ≥60 years: 57% vs. 69%, respectively), although the difference was not statistically significant (P=0.07). Gender was equally distributed (male: 54%, n=132; female: 46%, n=112) in patients who developed BCD. Conventional cytogenetics showed that patients without BCD were more often associated with abnormal cytogenetics (24%, n=9) as compared to LGLL-BCD (9%, n=5). Interestingly, BCD was found in 55 men and 54 women in whom only 6 patients had NK-LGLL while the remaining (n=103 patients) had T-LGLL suggesting a higher association with LGLL of T- rather than of NK-cell origin. Leukopenia was observed in 25/109 patients, with average absolute lymphocytes of 4.18 k/µL and LGL count of 2333 k/µL. Blood count showed: neutropenia in 44, anemia in 65, and thrombocytopenia in 29 out of 109 LGLL patients with BCD. TCR rearrangements were seen in 74 while somatic STAT3 mutations were observed in 37 LGLL patients while more enriched (44%, n=52) in LGLL without BCD. The association of other autoimmune conditions e.g., rheumatoid arthritis, was not different between the two groups (15% vs. 16% in LGLL with BCD vs. without; P=0.8). In sum, our investigation shows that BCD were frequent in LGLL and coexisted in 45% of the patients, commonly in the form of MGUS, and/ or hypergamaglobulinemia. Perhaps, the co-association of B-cell pathology with LGLL suggests that the two diseases either share pathogenetic driving mechanisms to enhance both B cells and T cells clones or that immunological dysfunction in setting of B cell dyscrasia could trigger/potentiate LGL expansion and/or transformation in this context. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
lilili的应助被xujiahao采纳,获得10
1秒前
晨曦发布了新的文献求助10
2秒前
XZM发布了新的文献求助10
2秒前
中中中发布了新的文献求助10
2秒前
逆水行舟发布了新的文献求助10
2秒前
Wuwj完成签到 ,获得积分10
2秒前
青椒豆丝完成签到 ,获得积分10
3秒前
5秒前
Lynn完成签到,获得积分10
6秒前
Bigmouse完成签到 ,获得积分10
6秒前
zhhhh完成签到,获得积分20
6秒前
万能图书馆的应助被慕慕君卿采纳,获得10
7秒前
丘比特的应助被初初初啊采纳,获得10
8秒前
情怀的应助被Meng采纳,获得10
8秒前
ping发布了新的文献求助10
10秒前
斯文败类的应助被大碗宽面采纳,获得10
10秒前
Maestro_S的应助被酱鱼采纳,获得10
10秒前
JamesPei的应助被陈月亮采纳,获得10
11秒前
水弘的应助被renn采纳,获得10
11秒前
小y完成签到,获得积分10
12秒前
12秒前
秋风的应助被lin采纳,获得20
14秒前
Charlie完成签到,获得积分10
15秒前
15秒前
15秒前
16秒前
16秒前
XJ发布了新的文献求助10
17秒前
18秒前
烟花的应助被耳东采纳,获得10
18秒前
慕慕君卿发布了新的文献求助10
18秒前
小二郎的应助被xujiahao采纳,获得10
19秒前
L10086完成签到 ,获得积分10
19秒前
何倩完成签到 ,获得积分10
19秒前
Songzhu完成签到,获得积分10
19秒前
gbh的应助被Oublie_le采纳,获得10
20秒前
byr完成签到,获得积分10
20秒前
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184008
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829656
捐赠科研通 7781040
什么是DOI,文献DOI怎么找? 3434187
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480658